Targeting immune cell glutamyl-prolyl-transfer RNA synthetase 1 (EPRS1) to prevent fibrosis after tubulointerstitial nephritis
Kidney International · 2024
DOI: 10.1016/j.kint.2024.02.007 ↗Kurz gefasst
Kommentar in der Zeitschrift Kidney International, 2024. Verfasst von Shishir Kumar Patel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, Nephritis, Interstitial. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Glutamyl-prolyl-transfer RNA synthetase 1 is an enzyme that connects glutamic acid and proline to transfer RNA during protein synthesis. In this issue, a study by Kang et al. examined the role of the immune cell glutamyl-prolyl-transfer RNA synthetase 1 in toxin-induced tubulointerstitial nephritis mice. The study demonstrated that blocking glutamyl-prolyl-transfer RNA synthetase 1 may be a therapeutic target to attenuate fibrosis after toxin-induced tubulointerstitial nephritis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA.
- Division of Nephrology, Johns Hopkins University, Baltimore, Maryland, USA. Electronic address: hrabb1@jhmi.edu.
Zitieren
APA
Patel, S. K., & Rabb, H. (2024). Targeting immune cell glutamyl-prolyl-transfer RNA synthetase 1 (EPRS1) to prevent fibrosis after tubulointerstitial nephritis. Kidney International. https://doi.org/10.1016/j.kint.2024.02.007
Vancouver
Patel SK, Rabb H. Targeting immune cell glutamyl-prolyl-transfer RNA synthetase 1 (EPRS1) to prevent fibrosis after tubulointerstitial nephritis. Kidney International. 2024. doi:10.1016/j.kint.2024.02.007
BibTeX
@article{Patel2024,
author = {Patel, Shishir Kumar and Rabb, Hamid},
title = {Targeting immune cell glutamyl-prolyl-transfer RNA synthetase 1 (EPRS1) to prevent fibrosis after tubulointerstitial nephritis},
journal = {Kidney International},
year = {2024},
doi = {10.1016/j.kint.2024.02.007}
}
EUVIMED